Home LiteratureArticle Details
PMID: 16617070 Published · ppublish English Journal Article Research Support, U.S. Gov't, Non-P.H.S.

A computational framework for the topological analysis and targeted disruption of signal transduction networks.

Biophysical journal ·Vol. 91 ·No. 1 ·2006-07-01 ·Pages 382-98

Dasika MS, Burgard A, Maranas CD

Abstract

In this article, optimization-based frameworks are introduced for elucidating the input-output structure of signaling networks and for pinpointing targeted disruptions leading to the silencing of undesirable outputs in therapeutic interventions. The frameworks are demonstrated on a large-scale reconstruction of a signaling network composed of nine signaling pathways implicated in prostate cancer. The Min-Input framework is used to exhaustively identify all input-output connections implied by the signaling network structure. Results reveal that there exist two distinct types of outputs in the signaling network that either can be elicited by many different input combinations or are highly specific requiring dedicated inputs. The Min-Interference framework is next used to precisely pinpoint key disruptions that negate undesirable outputs while leaving unaffected necessary ones. In addition to identifying disruptions of terminal steps, we also identify complex disruption combinations in upstream pathways that indirectly negate the targeted output by propagating their action through the signaling cascades. By comparing the obtained disruption targets with lists of drug molecules we find that many of these targets can be acted upon by existing drug compounds, whereas the remaining ones point at so-far unexplored targets. Overall the proposed computational frameworks can help elucidate input/output relationships of signaling networks and help to guide the systematic design of interference strategies.

MeSH Terms
Animals Biomarkers, Tumor/metabolism Computer Simulation Gene Silencing Gene Targeting/methods Humans Male Models, Biological Neoplasm Proteins/metabolism Neoplasms/metabolism Signal Transduction Tumor Cells, Cultured
Chemicals
Biomarkers, Tumor Neoplasm Proteins
Authors & Affiliations
3 authors, click to expand affiliations / ORCID
Dasika Madhukar S
Department of Chemical Engineering, The Pennsylvania State University, University Park, Pennsylvania 16802, USA.
Burgard Anthony
Maranas Costas D
References (70)
70 references, click to expand
  1. Biological networks and analysis of experimental data in drug discovery.
    Drug Discov Today. 2005 May 1;10(9):653-62 PMID: 15894230
  2. A cyclic pentapeptide derived from the second EGF-like domain of Factor VII is an inhibitor of tissue factor dependent coagulation and thrombus formation.
    Thromb Haemost. 2002 Jan;87(1):13-21 PMID: 11848442
  3. The organization of metabolic reaction networks: a signal-oriented approach to cellular models.
    Metab Eng. 2000 Jul;2(3):190-200 PMID: 11056061
  4. Modeling of signaling networks.
    Bioessays. 2002 Dec;24(12):1110-7 PMID: 12447976
  5. Combinatorial complexity of pathway analysis in metabolic networks.
    Mol Biol Rep. 2002;29(1-2):233-6 PMID: 12241063
  6. Thalidomide: emerging role in cancer medicine.
    Annu Rev Med. 2002;53:629-57 PMID: 11818493
  7. Computational modeling of the dynamics of the MAP kinase cascade activated by surface and internalized EGF receptors.
    Nat Biotechnol. 2002 Apr;20(4):370-5 PMID: 11923843
  8. Signaling networks: the origins of cellular multitasking.
    Cell. 2000 Oct 13;103(2):193-200 PMID: 11057893
  9. Minimal reaction sets for Escherichia coli metabolism under different growth requirements and uptake environments.
    Biotechnol Prog. 2001 Sep-Oct;17(5):791-7 PMID: 11587566
  10. Endothelial barrier disruption by VEGF-mediated Src activity potentiates tumor cell extravasation and metastasis.
    J Cell Biol. 2004 Oct 25;167(2):223-9 PMID: 15504909
  11. Genome-scale models of microbial cells: evaluating the consequences of constraints.
    Nat Rev Microbiol. 2004 Nov;2(11):886-97 PMID: 15494745
  12. Logical analysis of timing-dependent receptor signalling specificity: application to the insulin receptor metabolic and mitogenic signalling pathways.
    Biochem J. 1997 Sep 1;326 ( Pt 2):463-9 PMID: 9291119
  13. ETS transcription factors: possible targets for cancer therapy.
    Cancer Sci. 2004 Aug;95(8):626-33 PMID: 15298723
  14. A unified model for signal transduction reactions in cellular membranes.
    Biophys J. 2002 Feb;82(2):591-604 PMID: 11806904
  15. TRANSPATH: an integrated database on signal transduction and a tool for array analysis.
    Nucleic Acids Res. 2003 Jan 1;31(1):97-100 PMID: 12519957
  16. Flux coupling analysis of genome-scale metabolic network reconstructions.
    Genome Res. 2004 Feb;14(2):301-12 PMID: 14718379
  17. The chemical organization of signaling interactions.
    Bioinformatics. 2002 Jun;18(6):855-63 PMID: 12075021
  18. Role of eNOS in neovascularization: NO for endothelial progenitor cells.
    Trends Mol Med. 2004 Apr;10(4):143-5 PMID: 15162796
  19. Reduced fertility and postischaemic brain injury in mice deficient in cytosolic phospholipase A2.
    Nature. 1997 Dec 11;390(6660):622-5 PMID: 9403693
  20. The role of Grb2-associated proteins in T-cell activation.
    Immunol Today. 1997 Aug;18(8):401-6 PMID: 9267083
  21. Theory for the systemic definition of metabolic pathways and their use in interpreting metabolic function from a pathway-oriented perspective.
    J Theor Biol. 2000 Apr 7;203(3):229-48 PMID: 10716907
  22. Mitogen activated protein (MAP) kinase signal transduction pathways and novel anti-inflammatory targets.
    Gut. 2003 Jan;52(1):144-51 PMID: 12477778
  23. The IkappaB-NF-kappaB signaling module: temporal control and selective gene activation.
    Science. 2002 Nov 8;298(5596):1241-5 PMID: 12424381
  24. Complexity in biological signaling systems.
    Science. 1999 Apr 2;284(5411):92-6 PMID: 10102825
  25. The organization of metabolic reaction networks. II. Signal processing in hierarchical structured functional units.
    Metab Eng. 2001 Apr;3(2):138-50 PMID: 11289790
  26. VRAP is an adaptor protein that binds KDR, a receptor for vascular endothelial cell growth factor.
    J Biol Chem. 2000 Mar 3;275(9):6059-62 PMID: 10692392
  27. Emergent properties of networks of biological signaling pathways.
    Science. 1999 Jan 15;283(5400):381-7 PMID: 9888852
  28. The TRANSPATH signal transduction database: a knowledge base on signal transduction networks.
    Bioinformatics. 2001 Nov;17(11):1053-7 PMID: 11724734
  29. BIND: the Biomolecular Interaction Network Database.
    Nucleic Acids Res. 2003 Jan 1;31(1):248-50 PMID: 12519993
  30. Signaling from Ras to Rac and beyond: not just a matter of GEFs.
    EMBO J. 2000 Jun 1;19(11):2393-8 PMID: 10835338
  31. Robustness in bacterial chemotaxis.
    Nature. 1999 Jan 14;397(6715):168-71 PMID: 9923680
  32. The topology of the regulatory interactions predicts the expression pattern of the segment polarity genes in Drosophila melanogaster.
    J Theor Biol. 2003 Jul 7;223(1):1-18 PMID: 12782112
  33. Integrative analysis of the cancer transcriptome.
    Nat Genet. 2005 Jun;37 Suppl:S31-7 PMID: 15920528
  34. Robust perfect adaptation in bacterial chemotaxis through integral feedback control.
    Proc Natl Acad Sci U S A. 2000 Apr 25;97(9):4649-53 PMID: 10781070
  35. Design and constraints of the Drosophila segment polarity module: robust spatial patterning emerges from intertwined cell state switches.
    J Exp Zool. 2002 Oct 15;294(3):179-215 PMID: 12362429
  36. Rewiring MAP kinase pathways using alternative scaffold assembly mechanisms.
    Science. 2003 Feb 14;299(5609):1061-4 PMID: 12511654
  37. Therapeutic approaches in inflammatory bowel disease based on the immunopathogenesis.
    Rocz Akad Med Bialymst. 2004;49:22-30 PMID: 15631310
  38. Repression of the c-Jun trans-activation function by the adenovirus type 12 E1A 52R protein correlates with the inhibition of phosphorylation of the c-Jun activation domain.
    J Biol Chem. 1995 May 5;270(18):10754-63 PMID: 7738014
  39. Targeting multiple signaling pathways as a strategy for managing prostate cancer: multifocal signal modulation therapy.
    Integr Cancer Ther. 2004 Dec;3(4):349-80 PMID: 15523106
  40. The Database of Quantitative Cellular Signaling: management and analysis of chemical kinetic models of signaling networks.
    Bioinformatics. 2003 Feb 12;19(3):408-15 PMID: 12584128
  41. Topology and robustness in the Drosophila segment polarity network.
    PLoS Biol. 2004 Jun;2(6):e123 PMID: 15208707
  42. Topological analysis of mass-balanced signaling networks: a framework to obtain network properties including crosstalk.
    J Theor Biol. 2004 Mar 21;227(2):283-97 PMID: 14990392
  43. The PANTHER database of protein families, subfamilies, functions and pathways.
    Nucleic Acids Res. 2005 Jan 1;33(Database issue):D284-8 PMID: 15608197
  44. Ligand-activated retinoic acid receptor inhibits AP-1 transactivation by disrupting c-Jun/c-Fos dimerization.
    Mol Endocrinol. 1999 Feb;13(2):276-85 PMID: 9973257
  45. An integrated approach for inference and mechanistic modeling for advancing drug development.
    FEBS Lett. 2005 Mar 21;579(8):1878-83 PMID: 15763567
  46. Signal transduction. Imposing specificity on kinases.
    Science. 2003 Feb 14;299(5609):1025-7 PMID: 12586931
  47. DIP, the Database of Interacting Proteins: a research tool for studying cellular networks of protein interactions.
    Nucleic Acids Res. 2002 Jan 1;30(1):303-5 PMID: 11752321
  48. TRANSFAC: transcriptional regulation, from patterns to profiles.
    Nucleic Acids Res. 2003 Jan 1;31(1):374-8 PMID: 12520026
  49. Robustness of cellular functions.
    Cell. 2004 Sep 17;118(6):675-85 PMID: 15369668
  50. VEGF-receptor signal transduction.
    Trends Biochem Sci. 2003 Sep;28(9):488-94 PMID: 13678960
  51. Probing the performance limits of the Escherichia coli metabolic network subject to gene additions or deletions.
    Biotechnol Bioeng. 2001 Sep 5;74(5):364-75 PMID: 11427938
  52. RKIP downregulates B-Raf kinase activity in melanoma cancer cells.
    Oncogene. 2005 May 12;24(21):3535-40 PMID: 15782137
  53. The Molecule Pages database.
    Nature. 2002 Dec 12;420(6916):716-7 PMID: 12478304
  54. Molecular targets of the oncogenic transcription factor jun.
    Curr Cancer Drug Targets. 2003 Feb;3(1):41-55 PMID: 12570660
  55. Selective inhibition of tumor microvascular permeability by cavtratin blocks tumor progression in mice.
    Cancer Cell. 2003 Jul;4(1):31-9 PMID: 12892711
  56. A general definition of metabolic pathways useful for systematic organization and analysis of complex metabolic networks.
    Nat Biotechnol. 2000 Mar;18(3):326-32 PMID: 10700151
  57. Common and distinct elements in cellular signaling via EGF and FGF receptors.
    Science. 2004 Nov 26;306(5701):1506-7 PMID: 15567848
  58. Spatial range of autocrine signaling: modeling and computational analysis.
    Biophys J. 2001 Oct;81(4):1854-67 PMID: 11566760
  59. Thalidomide use: past history and current implications for practice.
    Oncol Nurs Forum. 2001 Apr;28(3):471-7; quiz 478-9 PMID: 11338756
  60. Mathematical models of protein kinase signal transduction.
    Mol Cell. 2002 May;9(5):957-70 PMID: 12049733
  61. Overview of the Alliance for Cellular Signaling.
    Nature. 2002 Dec 12;420(6916):703-6 PMID: 12478301
  62. Quantification of information transfer via cellular signal transduction pathways.
    FEBS Lett. 1997 Sep 8;414(2):430-4 PMID: 9315734
  63. MEK inhibitors: the chemistry and biological activity of U0126, its analogs, and cyclization products.
    Bioorg Med Chem Lett. 1998 Oct 20;8(20):2839-44 PMID: 9873633
  64. Illuminating drug discovery with biological pathways.
    FEBS Lett. 2005 Mar 21;579(8):1872-7 PMID: 15763566
  65. The systems biology markup language (SBML): a medium for representation and exchange of biochemical network models.
    Bioinformatics. 2003 Mar 1;19(4):524-31 PMID: 12611808
  66. The segment polarity network is a robust developmental module.
    Nature. 2000 Jul 13;406(6792):188-92 PMID: 10910359
  67. Reconstruction of cellular signalling networks and analysis of their properties.
    Nat Rev Mol Cell Biol. 2005 Feb;6(2):99-111 PMID: 15654321
  68. Optknock: a bilevel programming framework for identifying gene knockout strategies for microbial strain optimization.
    Biotechnol Bioeng. 2003 Dec 20;84(6):647-57 PMID: 14595777
  69. BIND--The Biomolecular Interaction Network Database.
    Nucleic Acids Res. 2001 Jan 1;29(1):242-5 PMID: 11125103
  70. Space in systems biology of signaling pathways--towards intracellular molecular crowding in silico.
    FEBS Lett. 2005 Mar 21;579(8):1783-8 PMID: 15763552
Article Info
Journal
Biophysical journal
Abbr.
Biophys J
ISSN
0006-3495
Published
2006-07-01
Epub
2006-00-14
Pages
382-98
Language
English
Region
United States
NLM ID
0370626
PMCID
PMC1479062
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]